Biosimilars are a prescription for better health.

Biosimilars could lead to over $54 billion in savings over the next ten years, giving 1.2 million patients access to needed medicines.

Learn More

The Biosimilars Council - Dark Transparent Overlay

Biosimilars: A needed alternative to costly care.

Utilization of innovative and very costly medicines is expected to grow exponentially in the coming years. With biosimilars, these advanced treatments are poised to become available at a lower cost to millions of patients in the United States. A positive regulatory environment can increase biosimilar adoption.

LEARN MORE

Browse our Resources

Hear more from experts on the potential of biosimilars and learn about Biosimilars Council efforts to increase biosimilar access for patients.

ALL RESOURCES

Want to keep up-to-date?

Enter your email address below and receive the Biosimilars Bulletin – our monthly newsletter with the most recent information on biosimilars in the United States.

  • This field is for validation purposes and should be left unchanged.

FDA Biosimilars Approvals

Find an up-to-date list of FDA approved biosimilars and launches.

Featured Reports & Resources

These resources provide answers around what biosimilars are, why they are important, how they can improve patient access, and how they can save the United States billions of dollars.

2020 Generics & Biosimilars Savings Report

Recent Tweets

Did you know the Biosimilars Council has a newsletter that includes the latest updates in the #biosimilars industry including policy movement, educational resources and upcoming events?

Subscribe to receive the Biosimilars Bulletin today: https://biosimilarscouncil.org/#homepage-form

Load More...